Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.

NCT02428426 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-04-28

No results posted yet for this study

Summary

To investigate the mucosal microbiome in human gastric intestinal etaplasia and duodenal tissue.

Conditions

  • Mucosal Microbiome
  • Gastric Intestinal Metaplasia
  • Duodenum

Interventions

OTHER

endomicroscopy, targeted biopsy and 16s rRNA gene sequencing

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • li yanqing, PhD,MD · Qilu Hospital, Shandong University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428426 on ClinicalTrials.gov